Investor mix
5 investors on record; lead investors include Mitsubishi UFJ Capital, Cyberdyne, DG Ventures, Hokkaido Venture Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 60% |
| Other / undisclosed | 2 | 40% |
Developer of probiotic medicines for gastrointestinal diseases
5 investors on record; lead investors include Mitsubishi UFJ Capital, Cyberdyne, DG Ventures, Hokkaido Venture Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 60% |
| Other / undisclosed | 2 | 40% |